Pengxiang Chen Selected Research

arachidonyltrifluoromethane

4/2022

Inhibiting the Cytosolic Phospholipase A2-Arachidonic Acid Pathway With Arachidonyl Trifluoromethyl Ketone Attenuates Radiation-Induced Lung Fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pengxiang Chen Research Topics

Disease

8	Neoplasms (Cancer) 01/2022 - 01/2017
8	Esophageal Squamous Cell Carcinoma 01/2020 - 03/2016
4	Esophageal Neoplasms (Esophageal Cancer) 01/2021 - 01/2017
2	Inflammation (Inflammations) 04/2022 - 03/2016
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2020 - 01/2017
2	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2019
2	Carcinogenesis 01/2020 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2019
2	Carcinoma (Carcinomatosis) 01/2018 - 09/2017
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 04/2022
1	Fibrosis (Cirrhosis) 04/2022
1	Lymphopenia (Lymphocytopenia) 01/2022
1	Dehydration (Water Stress) 01/2022
1	Nasopharyngeal Carcinoma 12/2021
1	Necrosis 12/2021
1	AIDS-Related Complex (ARC) 11/2021
1	Glioma (Gliomas) 11/2020
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 10/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Non-Muscle Invasive Bladder Neoplasms 01/2016
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2016

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2019 - 04/2016
2	AcidsIBA 04/2022 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2019
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	Arachidonate 12-Lipoxygenase (12 Lipoxygenase)IBA 01/2020 - 01/2019
2	Serum AlbuminIBA 09/2017 - 01/2017
2	Fibrinogen (Factor I)FDA Link 09/2017 - 01/2017
1	Arachidonic Acid (Vitamin F)IBA 04/2022
1	arachidonyltrifluoromethaneIBA 04/2022
1	Phospholipases A2 (Phospholipase A2)IBA 04/2022
1	Phospholipases (Phospholipase)IBA 04/2022
1	CollagenIBA 04/2022
1	AntibodiesIBA 01/2022
1	SHR-1701IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	ethyleneIBA 01/2022
1	Firefly LuciferasesIBA 01/2022
1	Protons (Proton)IBA 12/2021
1	APTIBA 12/2021
1	AmidesIBA 12/2021
1	Anthocyanins (Anthocyanin)IBA 11/2021
1	Verteporfin (Visudyne)FDA Link 01/2021
1	N-methyladenosineIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	6-methyladenineIBA 01/2021
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 11/2020
1	Thymine DNA GlycosylaseIBA 10/2020
1	ErbB Receptors (EGF Receptor)IBA 07/2020
1	PlatinumIBA 07/2020
1	DioxygenasesIBA 01/2020
1	PeroxiredoxinsIBA 01/2019
1	Hydroxyeicosatetraenoic Acids (HETE)IBA 01/2019
1	LDL CholesterolIBA 06/2017
1	CholesterolIBA 06/2017
1	LipidsIBA 06/2017
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2017
1	Indicators and Reagents (Reagents)IBA 01/2017

Therapy/Procedure

5	Radiotherapy 04/2022 - 01/2017
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2016
2	Esophagectomy 06/2017 - 03/2016
1	Immunotherapy 01/2022
1	Therapeutics 01/2016